Bio-Path Holdings Management
Management criteria checks 4/4
Bio-Path Holdings' CEO is Peter Nielsen, appointed in Jan 2007, has a tenure of 17.83 years. total yearly compensation is $827.12K, comprised of 69.5% salary and 30.5% bonuses, including company stock and options. directly owns 0.035% of the company’s shares, worth $1.15K. The average tenure of the management team and the board of directors is 17.8 years and 8.5 years respectively.
Key information
Peter Nielsen
Chief executive officer
US$827.1k
Total compensation
CEO salary percentage | 69.5% |
CEO tenure | 17.8yrs |
CEO ownership | 0.03% |
Management average tenure | 17.8yrs |
Board average tenure | 8.5yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Bio-Path Holdings' (NASDAQ:BPTH) Cash Burn Rate
Nov 05Bio-Path GAAP EPS of -$0.42 beats by $0.07
Aug 16Is Bio-Path Holdings (NASDAQ:BPTH) In A Good Position To Deliver On Growth Plans?
Jul 08Here's Why We're Not Too Worried About Bio-Path Holdings' (NASDAQ:BPTH) Cash Burn Situation
Mar 24Bio-Path Holdings (NASDAQ:BPTH) Is In A Good Position To Deliver On Growth Plans
Aug 17We Think Bio-Path Holdings (NASDAQ:BPTH) Needs To Drive Business Growth Carefully
Mar 26Will Bio-Path Holdings (NASDAQ:BPTH) Spend Its Cash Wisely?
Dec 11Dosing underway in Bio-Path's early-stage BP1002 study
Nov 19Bio-Path EPS beats by $0.07
Nov 13CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$12m |
Mar 31 2024 | n/a | n/a | -US$14m |
Dec 31 2023 | US$827k | US$575k | -US$16m |
Sep 30 2023 | n/a | n/a | -US$17m |
Jun 30 2023 | n/a | n/a | -US$17m |
Mar 31 2023 | n/a | n/a | -US$16m |
Dec 31 2022 | US$1m | US$555k | -US$14m |
Sep 30 2022 | n/a | n/a | -US$14m |
Jun 30 2022 | n/a | n/a | -US$13m |
Mar 31 2022 | n/a | n/a | -US$11m |
Dec 31 2021 | US$1m | US$530k | -US$10m |
Sep 30 2021 | n/a | n/a | -US$9m |
Jun 30 2021 | n/a | n/a | -US$10m |
Mar 31 2021 | n/a | n/a | -US$10m |
Dec 31 2020 | US$1m | US$510k | -US$11m |
Sep 30 2020 | n/a | n/a | -US$11m |
Jun 30 2020 | n/a | n/a | -US$10m |
Mar 31 2020 | n/a | n/a | -US$10m |
Dec 31 2019 | US$735k | US$490k | -US$9m |
Sep 30 2019 | n/a | n/a | -US$8m |
Jun 30 2019 | n/a | n/a | -US$9m |
Mar 31 2019 | n/a | n/a | -US$8m |
Dec 31 2018 | US$672k | US$490k | -US$9m |
Sep 30 2018 | n/a | n/a | -US$9m |
Jun 30 2018 | n/a | n/a | -US$8m |
Mar 31 2018 | n/a | n/a | -US$10m |
Dec 31 2017 | US$594k | US$475k | -US$8m |
Compensation vs Market: Peter's total compensation ($USD827.12K) is about average for companies of similar size in the US market ($USD650.00K).
Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.
CEO
Peter Nielsen (75 yo)
17.8yrs
Tenure
US$827,117
Compensation
Mr. Peter H. Nielsen, MBA, is a Co-Founded Bio-path Holdings, Inc. in 2007 and has been its Chairman, President, Chief Executive Officer, Chief Financial Officer and Treasurer since 2008. Mr. Nielsen licen...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 17.8yrs | US$827.12k | 0.035% $ 1.2k | |
Co-Founder | 17.8yrs | US$89.98k | 0% $ 0 | |
VP of Clinical Operations | 1.8yrs | no data | no data | |
Senior Vice President of Finance | no data | no data | no data | |
Senior Vice President of Research | no data | no data | no data |
17.8yrs
Average Tenure
Experienced Management: BPTH's management team is seasoned and experienced (17.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 16.8yrs | US$827.12k | 0.035% $ 1.2k | |
Co-Founder | 17.8yrs | US$89.98k | 0% $ 0 | |
Chairman of the Scientific Advisory Board | 9.3yrs | no data | no data | |
Independent Director | 6.8yrs | US$73.81k | 0% $ 0 | |
Member of the Scientific Advisory Board | 6.3yrs | no data | no data | |
Independent Director | 10.8yrs | US$85.31k | 0% $ 0 | |
Member of the Scientific Advisory Board | 7.8yrs | no data | no data | |
Independent Director | 2.7yrs | US$76.81k | 0% $ 0 |
8.5yrs
Average Tenure
54yo
Average Age
Experienced Board: BPTH's board of directors are considered experienced (8.5 years average tenure).